Joshua C. Curtin
- Aging top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 8
- Cancer-related Molecular Pathways 4
-
- Lung Cancer Treatments and Mutations 22
- Lung Cancer Diagnosis and Treatment 4
- Molecular Biology top 10%
- Retinoids in leukemia and cellular processes 4
-
- Cancer Genomics and Diagnostics 7
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
Joshua C. Curtin
32 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Endocrine and Autonomic Systems 291
- Aging 71
- Oncology 527
- Pulmonary and Respiratory Medicine 423
- Molecular Biology 791
Countries citing papers authored by Joshua C. Curtin
This map shows the geographic impact of Joshua C. Curtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua C. Curtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua C. Curtin more than expected).
Fields of papers citing papers by Joshua C. Curtin
This network shows the impact of papers produced by Joshua C. Curtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua C. Curtin. The network helps show where Joshua C. Curtin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joshua C. Curtin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 21 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 12 | |
| 10 | 2019 | 80 | |
| 11 | 2019 | 1 | |
| 12 | 2013 | 20 | |
| 13 | 2010 | 140 | |
| 14 | 2009 | 68 | |
| 15 | Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathwaysbreakdown → | 2007 | 572 |
| 16 | 2007 | 26 | |
| 17 | 2005 | 11 | |
| 18 | 2003 | 70 | |
| 19 | 2003 | 25 | |
| 20 | 2001 | 47 |
About Joshua C. Curtin
Joshua C. Curtin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (7 papers), Retinoids in leukemia and cellular processes (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (291 citations), Aging (71 citations) and Oncology (527 citations). Joshua C. Curtin has collaborated with scholars based in United States, South Korea and Spain. Frequent co-authors include Matthew V. Lorenzi, Mitchell A. Lazar, Mohammed Qatanani, Robert A. Reid, Nan Wu, Kenneth H. Pearce, Lei Yin, Derek J. Parks, G. Bruce Wisely and Roland E. Knoblauch. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Oncogene, Annals of Oncology and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.